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The tissue distribution of mRNAs encoding two lysosomal proteases, cathepsin B and cathepsin D, was 
examined using cloned cDNAs to probe Northern and dot blots of RNAs extracted from various rat tissues. 
Cathepsin B mRNA showed a wide range of variation in expression in the tissues analyzed with the highest 
concentrations found in spleen and kidney, while the cathepsin D mRNA levels were relatively uniform 
in these same tissues. Significant quantities of cathepsin B mRNA were detected in total RNA from isolated 
islets of Langerhans but was not detectable in equivalent amounts of RNA from whole pancreas. The wide 
variations in tissue levels of cathepsin B mRNA suggest hat tissue specific controls may regulate its expres- 
sion and are compatible with the participation of this protease in specialized cellular functions other than 
intralysosomal protein degradation. 
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1. INTRODUCTION 
Cathepsin B (EC 3.4.22.1) is a thiol activated 
protease which, together with the related cysteine 
proteases, cathepsins H and L, and the aspartyl 
protease, cathepsin D (EC 3.4.4.23), is believed to 
play a major role in intracellular protein degrada- 
tion in many tissues [l-3]. Cathepsin B has been 
purified from several mammalian sources [4-81 
and the primary sequences of the rat [9], human 
[lo] and a partial sequence of the porcine liver en- 
zymes [ 1 l] have been determined. Isolated mature 
cathepsin B usually consists of a mixture of single 
and two chain forms having a molecular mass of 
approx. 27 kDa and single glycosylation site is pre- 
sent in the mature enzyme [9,12]. Both cathepsin B 
and H share important structural homologies with 
papain, a thiol endoproteinase from plants [9]. 
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Although cathepsin B has been localized to 
lysosomes in some tissues and undoubtedly plays 
an important role in intracellular protein 
catabolism, evidence has accumulated in recent 
years suggesting that this protease, or its biosyn- 
thetic precursor form(s), may also have ex- 
tralysosomal functions. Thus, it has been proposed 
that cathepsin B-like thiol proteases may be in- 
volved in the processing of some peptide hormone 
precursors [13-161 and, recently, a higher 
molecular mass form of cathepsin B has been 
demonstrated in secretory granules from rat islets 
and a rat insulinoma cell line [ 171. A number of in- 
vestigators have also observed enhanced secretion 
of both latent and active forms of cathepsin B 
from malignant tumor cells and have suggested 
that cathepsin B or similar enzymes may be in- 
volved in tumor invasiveness [18-201. Such a 
multi-functional role for cathepsin B suggests that 
its gene(s) might be highly regulated and conse- 
quently that its expression may vary in different 
tissues in response to local stimuli or special 
demands. To investigate more fully the expression 
and role of cathepsin B, we recently have cloned 
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and sequenced cDNAs encoding rat, mouse and 
human preprocathepsin B ([21], unpublished). The 
nucleotide sequence data indicate that procathep- 
sin B from all 3 species contains a conserved pro- 
region of 61 residues amino-terminal to the do- 
main of mature cathepsin B. In this study, we have 
utilized cloned cDNA as a hybridization probe to 
measure the relative levels of cathepsin B mRNA in 
various rat tissues. For comparative purposes, we 
have measured the mRNA levels of another 
lysosomal enzyme, cathepsin D, in these tissues us- 
ing an available cloned human cathepsin D cDNA 
probe [21]. 
2. MATERIALS AND METHODS 
2.1. Materials 
Nitrocellulose paper was BA 85 (0.45 pm) from 
Schleicher and Schuell. [cu-32P]dCTP and 
[&-32P]CTP (spec. act., 3000 Ci/mmol) were from 
Amersham {Arlington Heights, IL). DEAE- 
membrane (NA-45) was purchased from Schleicher 
and Schuell. DNA was labelled with [cr-32P]dCTP 
using a nick translation kit bought from Amer- 
sham. Restriction enzymes were from New 
England Biolabs. A cloned cDNA for human 
cathepsin D was obtained from Dr J. Chirgwin (St. 
Louis, MO). 
2.2. RNA isu~ati~n 
Total RNA was isolated from tissues of 
Sprague-Dawley rats by a modified guanidine thio- 
cyanate procedure [22]. Total RNA was also ob- 
tained from a transplantable rat insulinoma [23]. 
The tissues were excised and frozen at - 70°C. 
After pulverization, aliquots were homogenized in 
equal volumes of SDS buffer (0.2 M Tris-HCl, pH 
9.0, 0.1 M HCI, 0.025 M EDTA, 1% SDS) and a 
mixture of phenol/chloroform/isoamylalcohoI 
(50: 50: 1) (1 g tissue/l0 ml solution). The nucleic 
acid containing aqueous phase was extracted with 
the organic solvent mixture twice and precipitated 
with ethanol. Each RNA sample was further 
purified by sedimentation through a CsCl cushion 
essentially according to Chirgwin et al. [24] to 
remove residual amounts of DNA. Approx. 2000 
islets of Langerhans were isolated from rat pan- 
creas by collagenase digestion [14] and total RNA 
was extracted as described above. 
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2.3. Dot and Northern blot analysis 
Dot blot analysis was performed with a template 
manifold apparatus (Schleicher and Schuell, 
Keene, NH). Total RNA was applied at three dif- 
ferent concentrations (10, 5 and 2 pg) for analysis 
of cathepsin B mRNA and at 5,2 and 1 ,ug concen- 
trations for analysis of cathepsin D mRNA. By ad- 
ding yeast tRNA, the final total RNA (rat plus 
yeast) concentration in each dot was identical (10 
and 5 pg, respectively). The RNA samples were 
denatured by incubation at 50°C for 1S min in 
1 .O M formaldehyde and 10 x SSC (1 x SSC = 
0.15 M, 0.015 M sodium citrate, pH 7.0). Samples 
were immediately chilled on ice and one volume of 
10 x SSC was added. Both nitrocellulose sheets 
and 3 MM Whatman paper were previously 
equilibrated with 10 x SSC. Following sample ap- 
plication, filters were dried for 2 h at 80°C. Dot 
blots were hybridized to 32P-labeled cDNA inserts 
of approx. 1000 bp corresponding to rat cathepsin 
B [21] and human cathepsin D [25] isolated from 
recombinant plasmids by digestion with EcoRI and 
electroelution after agarose gel ele~trophoresis. 
The eluted DNA fragment was bound to a DEAE- 
membrane, eluted by incubation at 65°C in 1.0 M 
NaCl, 0.001 M EDTA, 3.02 M HCl-Tris, pH 8.0, 
and Nick-translated. 
Hybridization and washing conditions have been 
described [21]. The relative abundance of mRNAs 
in the different tissue total RNA preparations was 
determined by scanning densitometry of filter 
autoradiographs. 
Northern blots of total RNA were prepared ac- 
cording to Thomas et al. [26]. The cDNA inserts 
for both cathepsins were isolated and labeled as 
described above. Conditions for hybridization and 
washing for the cathepsin B clone were as de- 
scribed in [21]. The washing temperature was 
decreased to 45°C for the human cathepsin D 
clone in dot and Northern blots. 
3. RESULTS 
The relative amounts of cathepsin B and D 
mRNA in the various rat tissues studied were 
measured by dot blot hybridization analysis using 
a rat cDNA probe for cathepsin B and a human 
cDNA probe for cathepsin D. Based on highly con- 
served amino acid sequence homology between 
cathepsin D from different species, we anticipated 
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Fig. 1. Distribution of cathepsin B mRNA in rat tissues. 
Total cellular RNA was applied at 3 different 
concentrations (10, 5, 2 pg) for 7 tissues (liver, brain, 
spleen, kidney, lung, heart and pancreas) and 
insulinoma or at a single concentration for islets of 
Langerhans and thymus RNA. 
Table 1 
Relative levels of cathepsin B and cathepsin D mRNAs 
in rat tissues 
Tissues Relative mRNA level 
Cathepsin B Cathepsin D 
Kidney 100 (lOO)a 100 
Spleen 80 (47) 134 
Lung 61 (13) 96 
Brain 47 (27) 85 
Heart 33 (10) 96 
Liver 20 (28) 83 
Thymus 12 85 
Insulinoma 7 65 
Islets 6 103 
Pancreas NDb 89 
a Relative levels of mature cathepsin B protein, 
measured by immunochemical methods, recalculated 
from data of Katunuma nd Kominami [27] 
b ND, not detectable 
that the human cDNA would hybridize specifically 
with rat cathepsin D mRNA. The results for the 
distribution of cathepsin B mRNA are shown in 
fig.1 and summarized in table 1. The dot blots 
revealed that cathepsin B mRNA was most abun- 
dant in kidney. It was also abundant in spleen, 
lung, brain and heart, in decreasing order. The 
relative mRNA level found in liver (20% of that in 
kidney) was somewhat lower than expected in view 
of the frequent use of this organ as a source of en- 
zyme. RNA obtained from islets of Langerhans 
and insulinoma cells gave signals in the dot blot 
hybridizations which were 7.0 and 8.0% relative to 
kidney whereas no signal was detected in similar 
amounts of RNA from whole pancreas. The 
distribution of cathepsin D mRNA in the same 
tissues is presented in fig.2 and summarized in 
table 1. Although the highest concentration of 
cathepsin D mRNA was found in spleen, uniform- 
ly large quantities were found in all the other 
tissues tested including whole pancreas. Control 
‘dots’ of yeast RNA did not react with either 
cathepsin probe. 
Northern blot analysis was also performed on 
the tissue RNA preparations. The size of cathepsin 
B mRNAs (fig.3) did not vary among the different 
tissues, in all instances showing the 2.3 kb size 
mRNA as noted earlier for rat liver [21]. No other 
significant bands were detected in any of the 
-5.6 
-4.4 
Fig.2. Determination of the size of cathepsin B mRNA 
in rat tissues. Total RNAs from liver (50 pg), insulinoma 
(50rg), islets (15 pg), pancreas (lO,~g), lung (5 pug), 
kidney (10 pg), liver (lopg), brain (10 pg), spleen 
(7.5 /cg), heart (12.5 pg) and thymus (7.5 pg) were used. 
The positions and sizes (in kb) of HindIII-digested 
hDNA are indicated. 
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Fig.3. Distribution of cathepsin D mRNA in rat tissues. 
Total cellular RNA was applied at three concentrations 
(5, 2 and 1 pg) for tissues and insulinoma nd at only 
one concentration for thymus and islets of Langerhans 
RNA. 
tissues examined. These findings are consistent 
with other results indicating that cathepsin B is en- 
coded by a single copy gene in several species in- 
cluding rats (S.J. Chan, unpublished). The size of 
the cathepsin D mRNA (not shown) was closely 
similar in size to that of cathepsin B mRNA, in 
agreement with the reported human cathepsin D- 
mRNA length of 2.2 kb [25]. The presence on the 
Northern blots of a distinct band for cathepsin D 
mRNA and the virtual absence of a band for 
cathepsin B mRNA in the pancreatic RNA sample 
confirms the results obtained above by dot 
hybridization, suggesting that the expression of 
cathepsin B in this organ is considerably higher in 
the islets of Langerhans than in the exocrine or 
ductal cells. 
4. DISCUSSION 
Here we have demonstrated that the expression 
of the cathepsin B gene, as reflected in the level of 
its mRNA transcripts, can vary over lo-fold in dif- 
ferent tissues from the rat. In contrast, the mRNA 
levels for another lysosomal proteinase, cathepsin 
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D, varied only 2-fold in these tissues. Although 
cathepsin B is related structurally to cathepsins H 
and L [2,9], as well as to calcium-dependent thiol 
proteases [28], no cross-hybridization to mRNA 
for these proteins was noted under the stringent 
conditions used. This finding, together with 
evidence from Southern blot analysis that rat 
cathepsin B is encoded by a single gene (S.J. Chart, 
unpublished), indicates that the observed varia- 
tions in cathepsin B mRNA signal result from dif- 
ferences in expression of this gene, rather than 
arising from a complex of several related genes. 
While these experiments were in progress, 
Katunuma and Kominami [27] published a report 
on the distribution of cathepsin B and H in rat 
tissues in which a sensitive immunochemical 
method was used to quantitate the amount of en- 
zyme present. Our results generally are in agree- 
ment with theirs and both methods indicate that 
the kidney contains the highest level of both 
cathepsin B mRNA and immunoreactive nzyme. 
However, our estimates of the relative level of liver 
cathepsin B mRNA is somewhat lower than the 
amount of measured enzyme while brain, lung, 
and heart all appear to contain relatively more 
mRNA than measurable nzyme. A number of fac- 
tors might account for such discrepancies in- 
cluding tissue differences in the translational effi- 
ciency of cathepsin B mRNA or the turnover rate 
of mature enzyme, the presence of various in- 
hibitors or stabilizers of the enzyme protein, or dif- 
ferential processing and subcellular compartmen- 
tation of precursor forms of cathepsin B (vide in- 
fra). Such precursors may not be reactive with an- 
tibodies to the mature enzyme which require prior 
denaturation of the protein ([2,17]; D.F. Steiner, 
unpublished). 
The wide variation in the levels of cathepsin B 
mRNA observed in this study and its virtual 
absence in exocrine pancreatic RNA, raises ques- 
tions as to its function as a constitutive component 
of lysosomes. A possible explanation is that 
lysosomes themselves are not homogeneous 
organelles but may be regulated to contain varying 
mixtures of hydrolytic enzymes suitable for dif- 
ferent sets of substrates in different tissues. Thus, 
the rather uniform distribution of cathepsin D 
mRNA in most tissues is consistent with the 
putative major role of this protease in general in- 
tracellular degradation of proteins. However, 
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cathepsin B might be more specifically involved in perhaps, in some cells, specialized endocytic 
the degradation of susceptible proteins that only vesicles engaged in limited proteolysis of ingested 
occur in certain tissues. For example, the presence external proteins. An essential element of this 
of relatively large amounts of cathepsin B mRNA potential multi-functional role is that some larger 
in spleen correlates well with the cytochemical precursor-derived form(s) may have specialized 
localization of large amounts of mature enzyme in proteolytic activity differing from that of mature 
macrophages and other phagocytic cells [27] and is cathepsin B. Further analysis of this role for pro- 
consistent with the possibility that cathepsin B may cathepsin B will be facilitated by the elucidation of 
catalyze critical rate-limiting steps in the degrada- the primary structure of preprocathepsin B via 
tion of ingested extracellular proteins. It could cDNA cloning (San Segundo, B. et al., in prepara- 
thus be involved in antigen processing in tion), as well as by the expression in vitro of this 
macrophages, a chloroquine-sensitive process in- precursor via recombinant DNA methods for fur- 
volving limited proteolysis of proteins in endocytic ther study of its properties and possible pathways 
vesicles [29]. of processing into proteolytically active forms. 
Our findings also support the possibility that 
cathepsin B or its precursor forms may have ex- 
tralysosomal function(s). Much interest has been 
evoked by suggestions that cathepsin B-like thiol 
proteases may be involved in the processing of 
some peptide hormone precursors [ 13,161 and pro- 
apolipoproteins [30,31], and by its possible role in 
malignant umors as a secreted protease associated 
with invasive behavior [l&20,32]. These putative 
functions imply that the sorting of procathepsin B 
as it passes through the Golgi stack is biphasic, 
allowing a portion of the precursor to enter the 
secretory pathways while a major fraction is 
transported to the lysosomes, presumably via the 
mannose 6-phosphate receptor pathway [33]. Dif- 
ferences in processing of procathepsin B in 
secretory vesicles as compared with the lysosomes 
might then result in the production of active 
derivatives of higher molecular mass having 
specialized proteolytic characteristics [ 161. In nor- 
mal cells or tissues low levels of secretion of 
lysosomal enzymes or their precursors may occur 
via non-regulated pathways [34], and in 
pathological situations such as I-cell disease [35] 
where the mannose 6-phosphate receptor is missing 
or defective, secretion via this pathway is increas- 
ed. Increased entry of procathepsin B into 
secretory pathways in neoplasms could possibly be 
attributable either to defective specific sorting 
functions or to overproduction of the enzyme, 
thereby exceeding sorting capabilities [34]. 
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